MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Yang, Rui ^a,c   Chen, Yongjun ^a   Tang, Cong ^b   Li, Hongbo ^a   Wang, Bing ^a   Yan, Qun ^a   Hu, Junbo ^a   Zou, Shengquan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c Fifth Hospital of Wuhan   (China)

Author keywords

CCA; Cell invasion; Cell proliferation; LIS1; miRNA

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; MICRORNA; MICRORNA 144; PLATELET ACTIVATING FACTOR ACETYLHYDROLASE ISOFORM 1B; PROTEIN KINASE B; UNCLASSIFIED DRUG; MICROTUBULE ASSOCIATED PROTEIN; MIRN144 MICRORNA, HUMAN; PAFAH1B1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CELL MIGRATION; CHOLANGIOCARCINOMA CELL LINE; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR INVASION; WESTERN BLOTTING; ANIMAL; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CELL PROLIFERATION; DNA MICROARRAY; EXPERIMENTAL NEOPLASM; GENE EXPRESSION PROFILING; GENETICS; HEK293 CELL LINE; INTRAHEPATIC BILE DUCT; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICE; MICE, NUDE; MICRORNAS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84924931473     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-917     Document Type: Article

References (36)

1. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, Sripa B, Hong ST: Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 2010,101(3):579-585. 10.1111/j.1349-7006.2009.01458.x
2. Tyson GL, El-Serag HB: Risk factors for cholangiocarcinoma. Hepatology 2011,54(1):173-184. 10.1002/hep.24351
3. Blechacz B, Gores GJ: Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008,48(1):308-321. 10.1002/hep.22310
4. Khan SA, Miras A, Pelling M, Taylor-Robinson SD: Cholangiocarcinoma and its management. Gut 2007,56(12):1755-1756. 10.1136/gut.2007.138859
5. Kaira K, Sunose Y, Ohshima Y, Ishioka NS, Arakawa K, Ogawa T, Sunaga N, Shimizu K, Tominaga H, Oriuchi N, Itoh H, Nagamori S, Kanai Y, Yamaguchi A, Segawa A, Ide M, Mori M, Oyama T, Takeyoshi I: Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. BMC Cancer 2013, 13:482. 10.1186/1471-2407-13-482
6. Singh P, Patel T: Advances in the diagnosis, evaluation and management of cholangiocarcinoma. Curr Opin Gastroenterol 2006,22(3):294-299. 10.1097/01.mog.0000218967.60633.64
7. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD: Cholangiocarcinoma. Lancet 2005,366(9493):1303-1314. 10.1016/S0140-6736(05)67530-7
8. Patel T: Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 2006,3(1):33-42. 10.1038/ncpgasthep0389
9. Zhou Q, Wang Y, Peng B, Liang L, Li J: The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma. BMC Cancer 2013, 13:244. 10.1186/1471-2407-13-244
10. Fan L, He F, Liu H, Zhu J, Liu Y, Yin Z, Wang L, Guo Y, Wang Z, Yan Q, Huang G: CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer 2011, 11:320. 10.1186/1471-2407-11-320
11. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004,116(2):281-297. 10.1016/S0092-8674(04)00045-5
12. Ebert MS, Sharp PA: Roles for microRNAs in conferring robustness to biological processes. Cell 2012,149(3):515-524. 10.1016/j.cell.2012.04.005
13. Nikitina EG, Urazova LN, Stegny VN: MicroRNAs and human cancer. Exp Oncol 2012,34(1):2-8.
14. Mendell JT, Olson EN: MicroRNAs in stress signaling and human disease. Cell 2012,148(6):1172-1187. 10.1016/j.cell.2012.02.005
15. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 2006,6(11):857-866. 10.1038/nrc1997
16. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006,130(7):2113-2129. 10.1053/j.gastro.2006.02.057
17. Meng F, Henson R, Wehbe-Janek H, Smith H, Ueno Y, Patel T: The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem 2007,282(11):8256-8264. 10.1074/jbc.M607712200
18. Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T: Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 2008,27(3):378-386. 10.1038/sj.onc.1210648
19. Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, Yang J, Paun B, Jin Z, Agarwal R, Hamilton JP, Abraham J, Georgiades C, Alvarez H, Vivekanandan P, Yu W, Maitra A, Torbenson M, Thuluvath PJ, Gores GJ, LaRusso NF, Hruban R, Meltzer SJ: MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology 2009,49(5):1595-1601. 10.1002/hep.22838
20. Yamanaka S, Campbell NR, An F, Kuo SC, Potter JJ, Mezey E, Maitra A, Selaru FM: Coordinated effects of microRNA-494 induce G(2)/M arrest in human cholangiocarcinoma. Cell Cycle 2012,11(14):2729-2738. 10.4161/cc.21105
21. Iwaki J, Kikuchi K, Mizuguchi Y, Kawahigashi Y, Yoshida H, Uchida E, Takizawa T: MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line. PLoS One 2013,8(7):e69496. 10.1371/journal.pone.0069496
22. An F, Yamanaka S, Allen S, Roberts LR, Gores GJ, Pawlik TM, Xie Q, Ishida M, Mezey E, Ferguson-Smith AC, Mori Y, Selaru FM: Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch. PLoS One 2012,7(10):e45606. 10.1371/journal.pone.0045606
23. Deryugina EI, Luo GX, Reisfeld RA, Bourdon MA, Strongin A: Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res 1997,17(5A):3201-3210.
24. Donald PR, Malan C: Cerebrospinal fluid lactate and lactate dehydrogenase levels as diagnostic aids in tuberculous meningitis. S Afr Med J 1985,67(1):19-20.
25. Tomita Y, Hariu A, Kato C, Seiji M: The possible processing of tyrosinase in the Golgi complexes of the melanocyte. J Dermatol 1985,12(1):43-46.
26. Lo FY, Chen HT, Cheng HC, Hsu HS, Wang YC: Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer. Lung Cancer-J Iaslc 2012,77(3):585-592. 10.1016/j.lungcan.2012.05.105
27. Jia W, Eneh JO, Ratnaparkhe S, Altman MK, Murph MM: MicroRNA-30c-2* expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9. Mol Cancer Res 2011,9(12):1732-1745. 10.1158/1541-7786.MCR-11-0245
28. Reid JF, Sokolova V, Zoni E, Lampis A, Pizzamiglio S, Bertan C, Zanutto S, Perrone F, Camerini T, Gallino G, Verderio P, Leo E, Pilotti S, Gariboldi M, Pierotti MA: miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Mol Cancer Res 2012,10(4):504-515. 10.1158/1541-7786.MCR-11-0342
29. Ikeda Y, Tanji E, Makino N, Kawata S, Furukawa T: MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer. Mol Cancer Res 2012,10(2):259-269. 10.1158/1541-7786.MCR-11-0035
30. Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, Palanisamy N, Voorhoeve PM, Tan P: Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 2011,17(9):2657-2667. 10.1158/1078-0432.CCR-10-3152
31. Jiang X, Huang H, Li Z, He C, Li Y, Chen P, Gurbuxani S, Arnovitz S, Hong GM, Price C, Ren H, Kunjamma RB, Neilly MB, Salat J, Wunderlich M, Slany RK, Zhang Y, Larson RA, Le Beau MM, Mulloy JC, Rowley JD, Chen J: MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proc Natl Acad Sci U S A 2012,109(47):19397-19402. 10.1073/pnas.1217519109
32. Zhang LY, Ho-Fun LV, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, Fu L: MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis 2013,34(2):454-463. 10.1093/carcin/bgs346
33. Iwaya T, Yokobori T, Nishida N, Kogo R, Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, Wakabayashi G, Mori M, Mimori K: Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis 2012,33(12):2391-2397. 10.1093/carcin/bgs288
34. Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, Qiu F, Lin J: miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling. FEBS J 2013,280(18):4531-4538. 10.1111/febs.12417
35. Yang N, Inaki M, Cliffe A, Rorth P: Microtubules and Lis-1/NudE/dynein regulate invasive cell-on-cell migration in Drosophila. PLoS One 2012,7(7):e40632. 10.1371/journal.pone.0040632
36. Xing Z, Tang X, Gao Y, Da L, Song H, Wang S, Tiollais P, Li T, Zhao M: The human LIS1 is downregulated in hepatocellular carcinoma and plays a tumor suppressor function. Biochem Biophys Res Commun 2011,409(2):193-199. 10.1016/j.bbrc.2011.04.117